Vericiguat
Vericiguat is used on targeting cyclic guanosine monophosphate in the treatment of heart failure.
| Catalog Number | API1350653201 |
| Alternative Name(s) | Methyl (4,6-diamino-2-(5-fluoro-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)pyrimidin-5-yl)carbamate;BAY1021189;Carbamic acid, N-[4,6-diamino-2-[5-fluoro-1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinyl]-, methyl ester;Vericiguat (BAY 1021189);MK-1242;methyl (4,6-diamino-2-(5-fluoro-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)pyrimidin-5-yl)carbamate (Vericiguat);Inhibitor,BAY-1021189,BAY 1021189,inhibit,Guanylate Cyclase,Vericiguat |
| Research Area | APIs for Chronic Cardiac Insufficiency |
| Molecular Formula | C19H16F2N8O2 |
| CAS# | 1350653-20-1 |
| Size | inquiry |
| Supplier Page | https://www.protheragen-ing.com/vericiguat-item-10014.html |